Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team
Research

Value Creators: Revenio

By Juha KinnunenAnalyst
Revenio Group
Download report (PDF)

Translation: Original report published in Finnish on 10/1/2024 at 12:15 noon EEST.

In the Value Creators concept, we highlight companies that have created substantial shareholder value. The reports do not include forecasts; they are based solely on historical data and key figures derived from it.

We evaluate companies based on the following indicators:  

  • Revenue development
  • Operating profit development and profitability (%)
  • Return on capital (%)
  • Cash flow generated from operations
  • Share price development and historical valuations  
  • Data is primarily sourced from Bloomberg

We look at the long-term development and all figures are presented with the time series 2014-2023. The reports do not constitute investment recommendations.

In this report, we introduce Revenio - a global leader in ophthalmic equipment and software solutions, with a focus on eye care solutions.

Stay up to date
Value Creators

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2023, the Group’s net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Read more on company page

Key Estimate Figures2024-08-08

202324e25e
Revenue96.6105.2120.9
growth-%-0.5 %8.9 %15.0 %
EBIT (adj.)28.528.636.9
EBIT-% (adj.)29.5 %27.2 %30.6 %
EPS (adj.)0.800.831.09
Dividend0.380.400.57
Dividend %1.5 %2.1 %3.0 %
P/E (adj.)31.523.017.5
EV/EBITDA22.015.411.7

Forum discussions

Well, now it’s high time to jump ship. Getinge, Volati, and Revenio all seem to have gotten undeserved appreciation during the corona turmoil...
3/31/2026, 12:44 PM
by tankerous
10
Bråsen’s predictions were pretty accurate when he worked as an analyst for DI. Four other companies might also be worth looking into. Swedes...
3/31/2026, 12:39 PM
by Matkalle...
8
In Revenio, Bråse sees a severely depressed valuation accelerating growth The picks from this fund manager with “clear” upside potential are...
3/31/2026, 11:57 AM
by Opa
8
Spotted on Nordnet, nothing new or amazing, but perhaps people will wake up a bit regarding Revenio:
3/31/2026, 10:29 AM
by MTES
21
This is a pretty convincing picture. Halfway to becoming a Dividend Aristocrat. Are the years when the dividend remained the same counted, or...
3/23/2026, 3:16 PM
by Sissos
13
However, this point is interesting: 20. Amendment of Article 4 of the Articles of Association The Board of Directors proposes that Article 4...
3/23/2026, 2:55 PM
by Sissos
35
Revenio Group Revenio Group Oyj: Yhtiökokouskutsu 2026 The notice of the Annual General Meeting (AGM) has now been issued. The AGM will be held...
3/23/2026, 2:50 PM
by Temew
8
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.